Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Ho

Showing results (111-120 of 192) with videos related to

Pageof 20
Sort By:
Journal of Affective Disorders|November 8, 2024
A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: Target engagement and rationale for the development in mental disordersHezekiah C T Au, Yang Jing Zheng, Gia Han Le, et al.
JAMA Neurology|December 5, 2022
Association of Hearing Aids and Cochlear Implants With Cognitive Decline and Dementia: A Systematic Review and Meta-analysisBrian Sheng Yep Yeo, Harris Jun Jie Muhammad Danial Song, Emma Min Shuen Toh, et al.
Journal of Affective Disorders|July 17, 2024
Preclinical and clinical efficacy of kappa opioid receptor antagonists for depression: A systematic reviewSabrina Wong, Gia Han Le, Shreya Vasudeva, et al.
Brain, Behavior, and Immunity|May 1, 2020
Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatryFengyi Hao, Wanqiu Tan, Li Jiang, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 25, 2022
Ketamine as potential treatment for postpartum depression: A narrative reviewDavid Chen-Li, Leanna M W Lui, Joshua D Rosenblat, et al.
Brain, Behavior, and Immunity|April 27, 2020
Is returning to work during the COVID-19 pandemic stressful? A study on immediate mental health status and psychoneuroimmunity prevention measures of Chinese workforceWanqiu Tan, Fengyi Hao, Roger S McIntyre, et al.
Expert Opinion on Pharmacotherapy|March 22, 2024
Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic reviewAlexia Leber, Ranuk Ramachandra, Felicia Ceban, et al.
Journal of Affective Disorders|January 8, 2021
A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusionsNelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
Journal of Psychiatric Research|March 11, 2021
The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic reviewJoshua D Di Vincenzo, Ashley Siegel, Orly Lipsitz, et al.
Advances in Therapy|April 30, 2021
Strategies to Prolong Ketamine's Efficacy in Adults with Treatment-Resistant DepressionEric P McMullen, Yena Lee, Orly Lipsitz, et al.
Pageof 20

Showing results (111-120 of 192) with videos related to

Sort By:
Pageof 20
Journal of Affective Disorders|November 8, 2024
A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: Target engagement and rationale for the development in mental disordersHezekiah C T Au, Yang Jing Zheng, Gia Han Le, et al.
JAMA Neurology|December 5, 2022
Association of Hearing Aids and Cochlear Implants With Cognitive Decline and Dementia: A Systematic Review and Meta-analysisBrian Sheng Yep Yeo, Harris Jun Jie Muhammad Danial Song, Emma Min Shuen Toh, et al.
Journal of Affective Disorders|July 17, 2024
Preclinical and clinical efficacy of kappa opioid receptor antagonists for depression: A systematic reviewSabrina Wong, Gia Han Le, Shreya Vasudeva, et al.
Brain, Behavior, and Immunity|May 1, 2020
Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatryFengyi Hao, Wanqiu Tan, Li Jiang, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 25, 2022
Ketamine as potential treatment for postpartum depression: A narrative reviewDavid Chen-Li, Leanna M W Lui, Joshua D Rosenblat, et al.
Brain, Behavior, and Immunity|April 27, 2020
Is returning to work during the COVID-19 pandemic stressful? A study on immediate mental health status and psychoneuroimmunity prevention measures of Chinese workforceWanqiu Tan, Fengyi Hao, Roger S McIntyre, et al.
Expert Opinion on Pharmacotherapy|March 22, 2024
Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic reviewAlexia Leber, Ranuk Ramachandra, Felicia Ceban, et al.
Journal of Affective Disorders|January 8, 2021
A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusionsNelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
Journal of Psychiatric Research|March 11, 2021
The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic reviewJoshua D Di Vincenzo, Ashley Siegel, Orly Lipsitz, et al.
Advances in Therapy|April 30, 2021
Strategies to Prolong Ketamine's Efficacy in Adults with Treatment-Resistant DepressionEric P McMullen, Yena Lee, Orly Lipsitz, et al.
Pageof 20